Verification of drug license & valid prescription is strongly advised for the users before dealing in medicines

Trulicity 1.5mg Pen Injection

₹ 4,675/Box

Strength1.5 mg
Packaging TypeBox
Usage / ApplicationHospital
Shelf Life24 Months
Storage ConditionsCool And Dry Place
Packaging Size0.5 ml
UsageFor Hospitals
AvailabilityIn Stock
View in Hindi ट्रुलिसिटी 1.5 मिग्रा पेन इंजेक्शन
 Trulicity is a once-weekly injectable prescription medicine for adults and children 10 years of age and older with type 2 diabetes used to improve blood sugar along with diet and exercise and also proven to reduce the risk of major cardiovascular events, such as death, heart attack, or stroke in adults

Exports To: United States Of America | United Kingdom | Australia | Sri Lanka | Brazil

Find products similar to Trulicity 1.5mg Pen Injection

Find related categories

Shipping Information

PriceExcluding all taxes
Ships fromMumbai
ShippingAs per delivery location

Interested in this product?Get Latest Price from the seller

About the Company

GST Registration Date
15-10-2023
Legal Status of Firm
Limited Company
Nature of Business
Trader - Wholesaler/Distributor
Number of Employees
Upto 10 People
Annual Turnover
1.5 - 5 Cr
IndiaMART Member Since
Aug 2019
GST
27AANCP7003N1ZY
Import Export Code (IEC)
AANCP*****
Exports to
United States Of America | United Kingdom | Australia | Sri Lanka | Brazil

Established in the year of 2023, We “Pelikas Healthcare Private Limited.” are Wholesaler and Exporter of an Pharmaceutical Tablets, Pharmaceutical Injections, Healthaid Products, etc. We direct all our activities to cater the expectations of customers by providing them excellent quality products as per their gratification. Moreover, we follow moral business policies and crystal pure transparency in all our transactions to keep healthy relations with the customers.
 
For our accomplishment story, we are grateful to our Mr. Abhishek Sanjaykumar Tiwari, whose continual backing and direction have been useful to us for attaining exponential development in the current market.